Ber Gerard

Track

Insider profile

Performance

Overall performance
1.2
Performance over holding periods
1.2
30 days 90 days 120 days
Average return -13% 8.2% 15.1%
Success rate 10% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Ber Gerard's trades of Y-mAbs Therapeutics, Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
337.95
Quantity 72,521
Value US$4,677,929
Transaction date
Planned sale
Price
465.21
Quantity 246 -31.2%
Value US$3,723,485
Transaction date
Planned sale
Price
205.34
Quantity 37,394 -11.3%
Value US$4,394,371
Transaction date
Planned sale
Price
96.23
Quantity 11,175 -30.4%
Value US$1,075,370
Transaction date
Proposed sale
Price
97.33
Quantity 15,500
Value US$1,508,615
Transaction date
Proposed sale
Price
12.00
Quantity 722
Value US$8,665
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-03 2024-09-03
PrS Proposed sale
72,521
337.95
US$4,677,929 		72,521 337.95 US$4,677,929
2024-08-14 2024-08-12
PlS Planned sale
246 -31.2%
465.21
US$3,723,485 		246 -31.2% 465.21 US$3,723,485
2024-08-14 2024-08-12
PlS Planned sale
37,394 -11.3%
205.34
US$4,394,371 		37,394 -11.3% 205.34 US$4,394,371
2024-08-14 2024-08-12
PlS Planned sale
11,175 -30.4%
96.23
US$1,075,370 		11,175 -30.4% 96.23 US$1,075,370
2024-08-12 2024-08-12
PrS Proposed sale
15,500
97.33
US$1,508,615 		15,500 97.33 US$1,508,615
2024-06-11 2024-06-10
S Sale
722 -31.0%
12.00
US$8,664 		722 -31.0% 12.00 US$8,664
2024-06-10 2024-06-10
PrS Proposed sale
722
12.00
US$8,665 		722 12.00 US$8,665
2022-05-12 2022-05-10
S Sale
1,277 -3.8%
58.19
US$74,309 		1,277 -3.8% 58.19 US$74,309